The Europe Anti-Obesity Drugs Market would witness market growth of 10.4% CAGR during the forecast period (2023-2029).
The pharmaceutical industry is witnessing a growth in the number of mergers and acquisitions taking place between businesses that are developing medications for metabolic illnesses such as diabetes, obesity, and other conditions of a similar nature. The pharmaceutical industry is currently putting into action a strategic plan in order to expand its drug portfolios in the area of metabolic illnesses, as well as to bring safe and effective new medications to the market. For instance, firms are entering into a strategic partnership to identify and develop therapeutic molecules for the treatment of metabolic disorders like obesity, diabetes, and other problems associated with these diseases.
In recent years, the pharmaceutical industry has focused on gut hormones such as amylin, glucagon-like peptide?1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), and (peptide tyrosine-tyrosine) PYY for drug development. These hormones play a crucial role in regulating appetite and weight. Several of these medications are utilized for the management of both type 2 diabetes and obesity.
In Germany, a significant proportion of the population, specifically 67% of men and 53% of women, are overweight. Approximately 23% of male adults and 24% of female adults are classified as obese. Obesity and being overweight can lead to various health problems and increase the risk of chronic illnesses. The rising prevalence and related illnesses result in significant healthcare and social welfare expenses. The problem of being overweight and obesity holds significant importance in the public sphere. The increasing government initiatives to counter obesity and its growing burden are expected to surge the demand for anti-obesity drugs for treatment and therefore dive the market growth in the region.
The Germany market dominated the Europe Anti-Obesity Drugs Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $205.5 million by 2029. The UK market is anticipated to grow at a CAGR of 9.5% during (2023 - 2029). Additionally, The France market would exhibit a CAGR of 11.2% during (2023 - 2029).
Based on Drug Type, the market is segmented into Prescription Drugs and Over the Counter Drugs. Based on Mechanism of Action, the market is segmented into Centrally Acting and Peripherally Acting. Based on Route of Administration, the market is segmented into Oral Route and Subcutaneous Route. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Anti-Obesity Drugs Market is Projected to reach USD 3.1 Billion by 2029, at a CAGR of 10.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, Novo Nordisk A/S, Rhythm Pharmaceuticals, Inc., Gelesis Holdings Inc. (PureTech Health), Currax Pharmaceuticals LLC (Currax Holdings USA LLC), Vivus LLC, CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH) and KVK Tech, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Drug Type
- Prescription Drugs
- Over The Counter Drugs
By Mechanism of Action
- Centrally Acting
- Peripherally Acting
By Route Of Administration
- Oral Route
- Subcutaneous Route
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Pfizer, Inc.
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline PLC
- Novo Nordisk A/S
- Rhythm Pharmaceuticals, Inc.
- Gelesis Holdings Inc. (PureTech Health)
- Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
- Vivus LLC
- CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH)
- KVK Tech, Inc.
TABLE 1 Europe Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 2 Europe Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 3 Europe Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 4 Europe Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 5 Europe Prescription Drugs Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Prescription Drugs Market by Country, 2023 - 2029, USD Million
TABLE 7 Europe Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
TABLE 9 Europe Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 10 Europe Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 11 Europe Centrally Acting Market by Country, 2019 - 2022, USD Million
TABLE 12 Europe Centrally Acting Market by Country, 2023 - 2029, USD Million
TABLE 13 Europe Peripherally Acting Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe Peripherally Acting Market by Country, 2023 - 2029, USD Million
TABLE 15 Europe Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 16 Europe Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 17 Europe Oral Route Market by Country, 2019 - 2022, USD Million
TABLE 18 Europe Oral Route Market by Country, 2023 - 2029, USD Million
TABLE 19 Europe Subcutaneous Route Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Subcutaneous Route Market by Country, 2023 - 2029, USD Million
TABLE 21 Europe Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 22 Europe Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 23 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 25 Europe Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 27 Europe Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 28 Europe Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 29 Europe Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
TABLE 30 Europe Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
TABLE 31 Germany Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 32 Germany Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 33 Germany Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 34 Germany Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 35 Germany Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 36 Germany Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 37 Germany Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 38 Germany Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 39 Germany Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 40 Germany Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 41 UK Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 42 UK Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 43 UK Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 44 UK Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 45 UK Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 46 UK Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 47 UK Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 48 UK Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 49 UK Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 UK Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 51 France Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 52 France Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 53 France Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 54 France Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 55 France Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 56 France Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 57 France Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 58 France Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 59 France Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 60 France Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 61 Russia Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 62 Russia Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 63 Russia Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 64 Russia Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 65 Russia Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 66 Russia Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 67 Russia Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 68 Russia Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 69 Russia Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 70 Russia Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 71 Spain Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 72 Spain Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 73 Spain Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 74 Spain Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 75 Spain Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 76 Spain Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 77 Spain Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 78 Spain Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 79 Spain Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 80 Spain Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 81 Italy Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 82 Italy Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 83 Italy Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 84 Italy Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 85 Italy Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 86 Italy Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 87 Italy Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 88 Italy Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 89 Italy Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 90 Italy Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 91 Rest of Europe Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 92 Rest of Europe Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 93 Rest of Europe Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 94 Rest of Europe Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 95 Rest of Europe Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 96 Rest of Europe Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 97 Rest of Europe Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 98 Rest of Europe Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 99 Rest of Europe Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 100 Rest of Europe Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 101 Key Information – Pfizer, Inc.
TABLE 102 Key Information – Boehringer Ingelheim International GmbH
TABLE 103 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 104 Key information – Novo Nordisk A/S
TABLE 105 Key Information – Rhythm Pharmaceuticals, Inc
TABLE 106 Key Information – Gelesis Holdings Inc.
TABLE 107 Key Information – Currax Pharmaceuticals LLC
TABLE 108 Key Information – Vivus LLC
TABLE 109 Key Information – CHEPLAPHARM Arzneimittel GmbH
TABLE 110 Key Information – KVK Tech, Inc.
List of Figures
FIG 1 Methodology for the research